Interlab Oy

Interlab Oy is a declared insider of Biohit Oyj, with filings sourced from Nasdaq Helsinki. We count 3 filings; the first trade dates from 5 November 2025 and the latest from 3 December 2025.

No open-market sale appears; the market trades are 3 purchases worth €4.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

Half of the purchases are above €1.4M and half below. Measured against the company's value, the median purchase equals 3.9% of market capitalisation, across 3 purchases where it is known. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 4 December 2025 with an open-market purchase (€600k) in Biohit Oyj. Filings reach the Nasdaq Helsinki feed a median of 2 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Nasdaq Helsinki. They describe what insiders did and are not a recommendation.